137 related articles for article (PubMed ID: 33197677)
1. Effects of a mind-body program on symptoms of depression and perceived stress among adults with neurofibromatosis type 2 who are deaf: A live-video randomized controlled trial.
Carter S; Greenberg J; Funes CJ; Macklin EA; Vranceanu AM
Complement Ther Med; 2021 Jan; 56():102581. PubMed ID: 33197677
[TBL] [Abstract][Full Text] [Related]
2. First report of quality of life in adults with neurofibromatosis 2 who are deafened or have significant hearing loss: results of a live-video randomized control trial.
Funes CJ; Mace RA; Macklin EA; Plotkin SR; Jordan JT; Vranceanu AM
J Neurooncol; 2019 Jul; 143(3):505-513. PubMed ID: 31049826
[TBL] [Abstract][Full Text] [Related]
3. Cultivating resiliency in patients with neurofibromatosis 2 who are deafened or have severe hearing loss: a live‑video randomized control trial.
Greenberg J; Carter S; Lester E; Funes CJ; Macklin EA; Plotkin S; Vranceanu AM
J Neurooncol; 2019 Dec; 145(3):561-569. PubMed ID: 31677033
[TBL] [Abstract][Full Text] [Related]
4. The relaxation response resiliency program (3RP) in patients with neurofibromatosis 1, neurofibromatosis 2, and schwannomatosis: results from a pilot study.
Vranceanu AM; Merker VL; Plotkin SR; Park ER
J Neurooncol; 2014 Oct; 120(1):103-9. PubMed ID: 25022450
[TBL] [Abstract][Full Text] [Related]
5. Mind-Body Treatment for International English-Speaking Adults With Neurofibromatosis via Live Videoconferencing: Protocol for a Single-Blind Randomized Controlled Trial.
Vranceanu AM; Zale EL; Funes CJ; Macklin EA; McCurley J; Park ER; Jordan JT; Lin A; Plotkin SR
JMIR Res Protoc; 2018 Oct; 7(10):e11008. PubMed ID: 30355560
[TBL] [Abstract][Full Text] [Related]
6. The impact of a virtual mind-body program on symptoms of depression and anxiety among international English-speaking adults with neurofibromatosis.
McDermott K; Bakhshaie J; Brewer J; Vranceanu AM
Am J Med Genet A; 2024 Jun; 194(6):e63543. PubMed ID: 38318960
[TBL] [Abstract][Full Text] [Related]
7. Mind-body therapy via videoconferencing in patients with neurofibromatosis: An RCT.
Vranceanu AM; Riklin E; Merker VL; Macklin EA; Park ER; Plotkin SR
Neurology; 2016 Aug; 87(8):806-14. PubMed ID: 27449066
[TBL] [Abstract][Full Text] [Related]
8. Adaptation of a Live Video Mind-Body Program to a Web-Based Platform for English-Speaking Adults With Neurofibromatosis: Protocol for the NF-Web Study.
Lester EG; Hopkins SW; Popok PJ; Vranceanu AM
JMIR Res Protoc; 2021 Jun; 10(6):e27526. PubMed ID: 34110294
[TBL] [Abstract][Full Text] [Related]
9. A Virtual Resiliency Intervention Promoting Resiliency for Parents of Children with Learning and Attentional Disabilities: A Randomized Pilot Trial.
Park ER; Perez GK; Millstein RA; Luberto CM; Traeger L; Proszynski J; Chad-Friedman E; Kuhlthau KA
Matern Child Health J; 2020 Jan; 24(1):39-53. PubMed ID: 31650412
[TBL] [Abstract][Full Text] [Related]
10. The impact of a mind-body program on multiple dimensions of resiliency among geographically diverse patients with neurofibromatosis.
Zale EL; Pierre-Louis C; Macklin EA; Riklin E; Vranceanu AM
J Neurooncol; 2018 Apr; 137(2):321-329. PubMed ID: 29275505
[TBL] [Abstract][Full Text] [Related]
11. Mind-Body Therapy via Videoconferencing in Patients With Neurofibromatosis: Analyses of 1-Year Follow-up.
Lester EG; Gates MV; Vranceanu AM
Ann Behav Med; 2021 Feb; 55(1):77-81. PubMed ID: 32421171
[TBL] [Abstract][Full Text] [Related]
12. Improvement in resiliency factors among adolescents with neurofibromatosis who participate in a virtual mind-body group program.
Lester EG; Macklin EA; Plotkin S; Vranceanu AM
J Neurooncol; 2020 Apr; 147(2):451-457. PubMed ID: 32078086
[TBL] [Abstract][Full Text] [Related]
13. Resilient youth with neurofibromatosis: Less perceived stress and greater life satisfaction after an 8-week virtual mind-body intervention.
Lester E; Vranceanu AM
J Psychosoc Oncol; 2021; 39(5):680-685. PubMed ID: 33191871
[TBL] [Abstract][Full Text] [Related]
14. Virtual mind-body treatment for adolescents with neurofibromatosis: Study protocol for a single-blind randomized controlled trial.
Reichman M; Riklin E; Macklin E; Vranceanu AM
Contemp Clin Trials; 2020 Aug; 95():106078. PubMed ID: 32634485
[TBL] [Abstract][Full Text] [Related]
15. Occurrence and Severity of Suicidal Ideation in Adults With Neurofibromatosis Participating in a Mind-Body RCT.
Lester EG; Wang KE; Blakeley JO; Vranceanu AM
Cogn Behav Neurol; 2023 Mar; 36(1):19-27. PubMed ID: 36651958
[TBL] [Abstract][Full Text] [Related]
16. The impact of a virtual mind-body program on resilience factors among international English-speaking adults with neurofibromatoses: secondary analysis of a randomized clinical trial.
Presciutti AM; Lester EG; Woodworth EC; Greenberg J; Bakhshaie J; Hooker JE; McDermott KA; Vranceanu AM
J Neurooncol; 2023 Jul; 163(3):707-716. PubMed ID: 37440099
[TBL] [Abstract][Full Text] [Related]
17. The feasibility and impact of delivering a mind-body intervention in a virtual world.
Hoch DB; Watson AJ; Linton DA; Bello HE; Senelly M; Milik MT; Baim MA; Jethwani K; Fricchione GL; Benson H; Kvedar JC
PLoS One; 2012; 7(3):e33843. PubMed ID: 22470483
[TBL] [Abstract][Full Text] [Related]
18. Mindfulness and bodily distress.
Fjorback LO
Dan Med J; 2012 Nov; 59(11):B4547. PubMed ID: 23171754
[TBL] [Abstract][Full Text] [Related]
19. Baseline characteristics of adults with neurofibromatosis enrolled on a psychosocial randomized controlled trial.
Fishbein NS; Vranceanu AM; Mace RA
J Neurooncol; 2022 Sep; 159(3):637-646. PubMed ID: 35925531
[TBL] [Abstract][Full Text] [Related]
20. Tailoring mind-body therapies to individual needs: patients' program preference and psychological traits as moderators of the effects of mindfulness-based cancer recovery and supportive-expressive therapy in distressed breast cancer survivors.
Carlson LE; Tamagawa R; Stephen J; Doll R; Faris P; Dirkse D; Speca M
J Natl Cancer Inst Monogr; 2014 Nov; 2014(50):308-14. PubMed ID: 25749597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]